DarioHealth Corp (NASDAQ:DRIO)
| 4.07 Delayed Data As of Jun 09 |  -0.10 / -2.40%Today’s Change | 3.13 Today|||52-Week Range 7.69 | -4.91% Year-to-Date |
Latest DRIO News | Press Releases
No recent news for DarioHealth Corp.
Today’s Trading
| Previous close | 4.17 |
| Today’s open | 4.25 |
| Day’s range | 4.07 - 4.25 |
| Volume | 1,963 |
| Average volume (3 months) | 145,500 |
| Market cap | $105.7M |
Data as of 3:59pm ET, 06/09/2023
Growth & Valuation
| Earnings growth (last year) | +46.56% |
| Earnings growth (this year) | +30.16% |
| Earnings growth (next 5 years) | +3.00% |
| Revenue growth (last year) | +34.82% |
| P/E ratio | NM |
| Price/Sales | 3.66 |
| Price/Book | 1.30 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ANIXAnixa Biosciences In... | -0.04 | -1.14% |
| NKTRNektar Therapeutics | -0.02 | -2.87% |
| SEELSeelos Therapeutics ... | -0.00 | -0.14% |
| ---- |
Data as of 3:59pm ET, 06/09/2023
Financials
| Next reporting date | August 14, 2023 |
| EPS forecast (this quarter) | -$0.46 |
| Annual revenue (last year) | $27.7M |
| Annual profit (last year) | -$60.0M |
| Net profit margin | -216.80% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
